Clover Health Investments Corp (NASDAQ:CLOV) price on Wednesday, July 10, remained unchanged to $1.34.
A look at the stock’s price movement, the close in the last trading session was $1.34. Turning to its 52-week performance, $1.63 and $0.61 were the 52-week high and 52-week low respectively. Overall, CLOV moved 21.82% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Clover Health Investments Corp’s market cap currently stands at around $665.23 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CLOV is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
CLOV’s current price about 13.01% and 31.11% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.70, while 7-day volatility ratio is 4.41% and 7.98% in the 30-day chart. Further, Clover Health Investments Corp (CLOV) has a beta value of 2.12, and an average true range (ATR) of 0.08.
If we refocus on Clover Health Investments Corp (NASDAQ:CLOV), historical trading data shows that trading volumes averaged 6.12 million over the past 3 months. The company’s latest data on shares outstanding shows there are 393.27 million shares.
The 24.44% of Clover Health Investments Corp’s shares are in the hands of company insiders while institutional holders own 18.01% of the company’s shares. Current price change has pushed the stock 40.74% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CLOV stock continues to rise going into the next quarter.
